Evidence map›Paper›PMID 41036487›Full record

ArticleSurgical case reports2025

Pathological Complete Response in Locally Advanced

Kazuki Ohta, Naoki Haratake, Shinkichi Takamori, Yuta Abe, Eika Kudo, Takahiro Sato, Kosuke Kamada, Daiki Noda, Miyuki Abe, Yohei Takumi and 4 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kazuki OhtaDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Naoki HaratakeDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Shinkichi TakamoriDepartment of Medical Oncology, Dana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Yuta AbeDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Eika KudoDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Takahiro SatoDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Kosuke KamadaDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Daiki NodaDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Miyuki AbeDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Yohei TakumiDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Michiyo MiyawakiDepartment of Thoracic Surgery, Oita Prefectural Hospital, Oita, Oita, Japan.
Tsutomu DaaDepartment of Diagnostic Pathology, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Kenji SugioDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Atsushi OsoegawaDepartment of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlectinib, a 2nd-generation anaplastic lymphoma kinase-tyrosine kinase inhibitor (ALK-TKI), is an established 1st-line therapy for advanced CASE PRESENTATION: A 41-year-old woman was diagnosed in the postpartum period with Stage IIIA (cT1cN2M0)

conclusionsThis case highlights the potential role of salvage surgery following alectinib in locally advanced

Indexed as

alectinibALK fusion gene–positive NSCLCALK tyrosine kinase inhibitor (ALK-TKI)anaplastic lymphoma kinase (ALK)locally advanced non–small cell lung cancer (NSCLC)pathological complete response (pCR)salvage surgery

Identifiers

PMID41036487
PMCPMC12483755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.